MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- CRESTCHEM (chemicals & pesticides)
- CRESTCHEM Financial Data
CRESTCHEM Fact Sheet (CREM)
FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit
Here is the latest financial fact sheet of CRESTCHEM. For more details, see the CRESTCHEM quarterly results and CRESTCHEM share price and chart.
CRESTCHEM Price History
| % ch | % | -5.0 |
| No. of shares | m | 3.00 |
| % ch week | % | -17.4 |
| % ch 1-mth | % | -3.6 |
| % ch 12-mth | % | -44.8 |
| 52 week H/L | Rs | 75.9/23.8 |
CRESTCHEM Financials
| No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
|---|
| CRESTCHEM EQUITY SHARE DATA | |||||||
|---|---|---|---|---|---|---|---|
| High | Rs | 13 | 14 | 15 | 15 | 16 | |
| Low | Rs | 9 | 9 | 12 | 12 | 11 | |
| Sales per share (Unadj.) | Rs | 0.4 | 0.5 | 0.2 | 0.3 | 20.7 | |
| Earnings per share (Unadj.) | Rs | 0.3 | -0.5 | -0.6 | -0.6 | 1.5 | |
| Diluted earnings per share | Rs | 0.3 | -0.5 | -0.6 | -0.6 | 1.5 | |
| Cash flow per share (Unadj.) | Rs | 0.3 | -0.5 | -0.6 | -0.5 | 1.5 | |
| Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
| Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
| Book value per share (Unadj.) | Rs | 3.3 | 2.8 | 2.1 | 1.6 | 3.1 | |
| Adj. book value per share | Rs | 3.3 | 2.8 | 2.1 | 1.6 | 3.1 | |
| Shares outstanding (eoy) | m | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | |
| Price / Sales ratio | x | 24.8 | 24.4 | 77.0 | 38.0 | 0.6 | |
| Avg P/E ratio | x | 38.3 | -21.2 | -20.7 | -23.4 | 8.8 | |
| P/CF ratio (eoy) | x | 38.2 | -21.2 | -21.0 | -25.1 | 8.4 | |
| Price / Book Value ratio | x | 3.3 | 4.1 | 6.2 | 8.4 | 4.3 | |
| Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
| Avg Mkt Cap | Rs m | 33 | 34 | 40 | 40 | 39 | |
| Total wages/salary | Rs m | 1 | 1 | 1 | 1 | 1 | |
| CRESTCHEM INCOME DATA | |||||||
|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 1 | 1 | 1 | 1 | 62 | |
| Other income | Rs m | 2 | 1 | 0 | 0 | 0 | |
| Total revenues | Rs m | 3 | 2 | 1 | 1 | 62 | |
| Gross profit | Rs m | -1 | -2 | -2 | -2 | 6 | |
| Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | Rs m | 1 | -2 | -2 | -2 | 6 | |
| Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Tax | Rs m | 0 | 0 | 0 | 0 | 1 | |
| Profit after tax | Rs m | 1 | -2 | -2 | -2 | 4 | |
| Gross profit margin | % | -45.7 | -143.0 | -475.1 | -161.9 | 9.2 | |
| Effective tax rate | % | 27.5 | 0 | 13.7 | -2.5 | 22.1 | |
| Net profit margin | % | 64.8 | -115.6 | -372.3 | -163.1 | 7.2 | |
| CRESTCHEM BALANCE SHEET DATA | |||||||
|---|---|---|---|---|---|---|---|
| Current assets | Rs m | 9 | 14 | 6 | 6 | 9 | |
| Current liabilities | Rs m | 4 | 7 | 2 | 4 | 2 | |
| Net working cap to sales | % | 379.1 | 514.5 | 726.8 | 204.4 | 11.3 | |
| Current ratio | x | 2.2 | 2.1 | 3.2 | 1.5 | 4.6 | |
| Inventory Days | Days | 1,272 | 205 | 875 | 414 | 7 | |
| Debtors Days | Days | 319 | 465 | 675 | 289 | 2 | |
| Net fixed assets | Rs m | 5 | 1 | 2 | 2 | 2 | |
| Share capital | Rs m | 30 | 30 | 30 | 30 | 30 | |
| "Free" reserves | Rs m | -20 | -22 | -24 | -25 | -21 | |
| Net worth | Rs m | 10 | 8 | 6 | 5 | 9 | |
| Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Total assets | Rs m | 14 | 15 | 8 | 9 | 11 | |
| Interest coverage | x | 8.4 | -2.7 | -31.0 | -26.5 | 115.0 | |
| Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
| Sales to assets ratio | x | 0.1 | 0.1 | 0.1 | 0.1 | 5.5 | |
| Return on assets | % | 7.3 | -7.9 | -23.7 | -19.0 | 39.9 | |
| Return on equity | % | 8.6 | -19.3 | -30.1 | -35.7 | 48.3 | |
| Return on capital | % | 13.4 | -14.1 | -33.7 | -33.5 | 62.6 | |
| Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
| Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
| Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Net fx | Rs m | 0 | 0 | 0 | 0 | 0 | |
| CRESTCHEM CASH FLOW | |||||||
|---|---|---|---|---|---|---|---|
| From Operations | Rs m | -3 | 0 | -7 | 0 | 3 | |
| From Investments | Rs m | 3 | 6 | 1 | 0 | -3 | |
| From Financial Activity | Rs m | 0 | 0 | 0 | 0 | 0 | |
| Net Cashflow | Rs m | 1 | 6 | -6 | 0 | 0 | |
Share Holding
|
Company Information
|
|||||||||||||||||||||||||||||||||
| YEAR OF INC: 1991 | BSE CODE: 526269 | FV (Rs): 10 | DIV YIELD (%): - |
More Chemicals & Pesticides Company Fact Sheets: S H KELKAR & CO. PIDILITE INDUSTRIES KANEL INDUSTRIES TATA CHEMICALS PAUSHAK.
Compare CRESTCHEM With: S H KELKAR & CO. PIDILITE INDUSTRIES KANEL INDUSTRIES TATA CHEMICALS PAUSHAK.
Today's Market
Sensex Ends 153 Points Higher; Kotak Mahindra Bank & HCL Tech Among Top Nifty Gainers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.
Views on news
Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)
Sep 14, 2021Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?
Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)
Aug 24, 2021The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.
Understanding Aarti Industries' Demerger (Views On News)
Aug 20, 2021Will the pharma unit's demerger unlock value for shareholders?
What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)
Aug 20, 2021What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?
Pidilite Results Review: Net Profit Spikes as Sales Rise 121% (Views On News)
Aug 12, 2021Pidilite posts strong sales growth and a multi-fold jump in bottomline.
More Views on NewsMost Popular
Infosys vs TCS: Which is Better? (Views On News)
Nov 26, 2021In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.
This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)
Nov 24, 2021Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.
Don't Sell these Stocks if the Market Falls (Profit Hunter)
Nov 17, 2021These are the 3 types of stocks that you should not sell in a market crash.
MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)
Nov 20, 2021The Rs 19 bn issue is set to hit the market soon.
How to Find Your Next 10-Bagger in this Market (Profit Hunter)
Nov 19, 2021The #1 make or break factor in your portfolio you shouldn't ignore.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2022
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: How to Profit from Sensex 100,000
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK CRESTCHEM
- Track your investment in CRESTCHEM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON CRESTCHEM
CRESTCHEM - GODREJ INDUSTRIES COMPARISON
COMPARE CRESTCHEM WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
APP
EQUITYMASTER SUPPORTS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.